FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:852-854 September 12, 2002 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Cunningham, G. Related Article by Woods, W. G. Related Article by Schilling, F. H. PubMed Citation

To the Editor: In their discussion, Schilling et al. (April 4 issue),¹ noting that screening for neuroblastoma at six months of age in Japan was reported to result in high survival rates among patients whose disease was detected by screening, as well as in reduced mortality as compared with that in a historical control group, expressed the concern that the ascertainment of cases among the screened cohorts in Japan was not complete. We have addressed this question and found no differences in the cumulative incidence of advanced-stage neuroblastoma and the cumulative mortality rates for neuroblastoma between screened and unscreened children . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.